TUSK Practice Sales

Just Released: TUSK's Q3 2026 Dental Market Report
Download Here: https://hubs.li/Q04nN-_w0

The first half of 2026 brought major shifts to the dental M&A landscape. From DSO recapitalizations and mergers to shifting buyer priorities, the market continues to evolve while demand for high-quality practices remains strong.

Our Q3 2026 Dental Market Report examines the key developments that have shaped the market so far this year and the trends practice owners should be watching in the months ahead, including:

➡️ How major capital market activity is reshaping buyer competition.
➡️ What today's buyers are prioritizing, and the key factors causing them to walk away from deals.
➡️ Why geography is playing a bigger role in practice valuations and buyer interest.
➡️ Why preparation matters more than ever for owners considering a transition in the next one to three years.
and more...

Whether you're planning a transition or just want to stay informed, this report provides a data-driven look at where the market stands today and where it's headed next.

🚨 Open to ALL Dykema DSO Conference Attendees 🚨
📅 July 15, 2026 | 8:00 AM – 4:00 PM
🔗 Register here: https://hubs.li/Q04mh2gf0

Private equity markets have tightened. LP patience is thinning. The first dental IPO window is on the horizon.

This panel brings together some of the most powerful voices in the DSO industry for a rare, candid discussion on the questions that typically stay off-stage: What does your cap table look like right now? What is genuinely blocking the path to liquidity?

These are the conversations shaping decisions in boardrooms and investment committees across the industry right now.

Moderated by:
Tom Creegan, Director of Healthcare Investment Banking, Raymond James

Featuring:
Nic Adamson, Director of Healthcare ECM, Raymond James
J. Hedrick, CEO, Smile Doctors
Justin Puckett, President, MB2 Dental

This is a can't miss session. Expect direct perspectives, real-time market insight, and a level of transparency that rarely makes it into a public forum, focused on the factors that ultimately drive value creation and exit outcomes across the DSO landscape.

Dermatology buyers are well capitalized and actively acquiring, but the bar for what earns a premium offer has risen.

Buyers are prioritizing provider depth, geographic density, integrated medical and aesthetic services, and operational infrastructure that runs beyond the founder. Practices without those qualities are seeing fewer competitive offers.

If you're a dermatologist thinking about a transition, TUSK's Q2 2026 Dermatology M&A Market Report tells you exactly where the market stands and what buyers are looking for right now.

Read the full report here: https://hubs.li/Q04lLP1l0

🚨Open to ALL Dykema DSO Conference Attendees🚨
July 15, 2026 | 8 AM – 4 PM
Register here: https://hubs.li/Q04lzS-M0

We're thrilled to have Matt Krauss, Partner and Chief Investment Officer at Corient, presenting one of the most anticipated sessions at the TUSK M&A Workshop during the 2026 Dykema DSO Conference this July.

His session, http://U.S. Economy Outlook and Expert Predictions, explores the key forces shaping today’s market. From tariffs, labor costs, and employment trends to M&A activity, upcoming IPOs, and the growing role of AI in investment decision-making, Matt will provide a clear perspective on the macroeconomic landscape and what it means for practice owners.

If you've been trying to make sense of where the economy is headed and what it means for your practice, this is the clearest explanation you'll hear all year.

The workshop is limited to 100 attendees. We hope to see you there!